Dong Sung Bio Pharm.Co.,Ltd.
Symbol: 002210.KS
KSC
5240
KRWDzisiejsza cena rynkowa
-57.7739
Wskaźnik P/E
-0.8344
Wskaźnik PEG
119.82B
Kapitalizacja MRK
- 0.00%
Rentowność DIV
Dong Sung Bio Pharm.Co.,Ltd. (002210-KS) Sprawozdania finansowe
Bilans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 21733.89 | 6435.4 | 4093.8 | 5142.8 | |||||||||||||||||
balance-sheet.row.short-term-investments | -3073.9 | 0 | 0 | 2002.6 | |||||||||||||||||
balance-sheet.row.net-receivables | 127499.54 | 31290.9 | 35361.6 | 29324.5 | |||||||||||||||||
balance-sheet.row.inventory | 72346.52 | 19477.1 | 14933.8 | 15519.1 | |||||||||||||||||
balance-sheet.row.other-current-assets | 16601.77 | 3611.5 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-current-assets | 238181.72 | 60814.9 | 54389.2 | 49986.3 | |||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 172690.32 | 42725.5 | 43960.4 | 37377.8 | |||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.intangible-assets | 3645.02 | 978.8 | 855.8 | 942.7 | |||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 3645.02 | 978.8 | 855.8 | 942.7 | |||||||||||||||||
balance-sheet.row.long-term-investments | 12525.06 | 7719.6 | 510.2 | -1606.9 | |||||||||||||||||
balance-sheet.row.tax-assets | 11078.52 | 0 | -510.2 | 17882 | |||||||||||||||||
balance-sheet.row.other-non-current-assets | 18636.95 | 2734.6 | 8496.6 | 0 | |||||||||||||||||
balance-sheet.row.total-non-current-assets | 218575.87 | 54158.4 | 53312.9 | 54595.6 | |||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-assets | 456757.59 | 114973.3 | 107702.1 | 104581.9 | |||||||||||||||||
balance-sheet.row.account-payables | 47580.16 | 11261.1 | 8852 | 6858.8 | |||||||||||||||||
balance-sheet.row.short-term-debt | 112670.19 | 24732.5 | 29274 | 19714 | |||||||||||||||||
balance-sheet.row.tax-payables | 66.53 | 0 | 418.8 | 262.1 | |||||||||||||||||
balance-sheet.row.long-term-debt-total | 52132.34 | 18522.4 | 7761.9 | 9600.8 | |||||||||||||||||
Deferred Revenue Non Current | 17174.11 | 17.9 | 0 | 9113.3 | |||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 10739.73 | - | - | - | |||||||||||||||||
balance-sheet.row.other-current-liab | 60212.7 | 8850.2 | 9183.7 | 3729.5 | |||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 95537.15 | 30327.1 | 17321.6 | 20552.3 | |||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.capital-lease-obligations | 231.81 | 17.9 | 104.1 | 55.7 | |||||||||||||||||
balance-sheet.row.total-liab | 289693.7 | 75171 | 64892.8 | 58141.5 | |||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.common-stock | 104403.88 | 26101 | 26101 | 26101 | |||||||||||||||||
balance-sheet.row.retained-earnings | 4190.1 | -3006.9 | 1153.1 | -2570.8 | |||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 11151.02 | 2787.8 | 2787.8 | 2787.8 | |||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 47318.89 | 13920.5 | 12767.5 | 20122.4 | |||||||||||||||||
balance-sheet.row.total-stockholders-equity | 167063.89 | 39802.3 | 42809.3 | 46440.4 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 456757.59 | 114973.3 | 107702.1 | 104581.9 | |||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-equity | 167063.89 | 39802.3 | 42809.3 | 46440.4 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 456757.59 | - | - | - | |||||||||||||||||
Total Investments | 9451.15 | 7719.6 | 510.2 | 395.7 | |||||||||||||||||
balance-sheet.row.total-debt | 164820.39 | 43272.8 | 37035.8 | 29314.8 | |||||||||||||||||
balance-sheet.row.net-debt | 147179.16 | 36837.4 | 32942 | 26174.6 |
Rachunek przepływów pieniężnych
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -2073.91 | -2073.9 | -2121.7 | -4312.8 | |||||||||||||||||
cash-flows.row.depreciation-and-amortization | 2082.09 | 2046 | 2119.7 | 2222.6 | |||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.change-in-working-capital | -5165.38 | -5165.4 | -4348.3 | -2543.3 | |||||||||||||||||
cash-flows.row.account-receivables | 2887.7 | 2887.7 | -4280.9 | -1791.5 | |||||||||||||||||
cash-flows.row.inventory | -3965.32 | -3965.3 | 629.7 | 4466.7 | |||||||||||||||||
cash-flows.row.account-payables | 1519.79 | 1519.8 | 1995 | -2870.6 | |||||||||||||||||
cash-flows.row.other-working-capital | -5607.55 | -5607.6 | -2692.1 | -2348 | |||||||||||||||||
cash-flows.row.other-non-cash-items | 863.87 | 900 | 467.6 | 1882 | |||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -4293.33 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -923.56 | -923.6 | -642.9 | -2323.5 | |||||||||||||||||
cash-flows.row.acquisitions-net | 32.78 | 18.2 | 74.3 | -197.7 | |||||||||||||||||
cash-flows.row.purchases-of-investments | -48.49 | -57.5 | -56.2 | -10994.9 | |||||||||||||||||
cash-flows.row.sales-maturities-of-investments | -32.78 | 0 | 2019.9 | 14989.6 | |||||||||||||||||
cash-flows.row.other-investing-activites | 44.34 | 35.2 | -756.9 | -11173.2 | |||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -927.71 | -927.7 | 638.3 | -9699.8 | |||||||||||||||||
cash-flows.row.debt-repayment | -33936.52 | -1229.6 | -44052.3 | -26435.5 | |||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 8455.4 | |||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | -1996.4 | -2990.4 | |||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | -8455.4 | |||||||||||||||||
cash-flows.row.other-financing-activites | 41503.88 | 8797 | 50289 | 30657.7 | |||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 7567.35 | 7567.4 | 4240.2 | 1231.8 | |||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -4.71 | -4.7 | -42.3 | 7.6 | |||||||||||||||||
cash-flows.row.net-change-in-cash | 2341.6 | 2341.6 | 953.6 | -11211.9 | |||||||||||||||||
cash-flows.row.cash-at-end-of-period | 17641.23 | 6435.4 | 4093.8 | 3140.2 | |||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 15299.63 | 4093.8 | 3140.2 | 14352.1 | |||||||||||||||||
cash-flows.row.operating-cash-flow | -4293.33 | -4293.3 | -3882.6 | -2751.5 | |||||||||||||||||
cash-flows.row.capital-expenditure | -923.56 | -923.6 | -642.9 | -2323.5 | |||||||||||||||||
cash-flows.row.free-cash-flow | -5216.9 | -5216.9 | -4525.5 | -5075.1 |
Wiersz rachunku zysków i strat
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 88593.59 | 88593.6 | 93328.2 | 84407.7 | |||||||||||||||||
income-statement-row.row.cost-of-revenue | 47447.64 | 47943.9 | 51272.8 | 50864 | |||||||||||||||||
income-statement-row.row.gross-profit | 41145.95 | 40649.6 | 42055.4 | 33543.6 | |||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||
income-statement-row.row.research-development | 4169.12 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-general-administrative | 12376.07 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 24762.64 | - | - | - | |||||||||||||||||
income-statement-row.row.other-expenses | -20425.25 | -221 | 12200 | 12364.1 | |||||||||||||||||
income-statement-row.row.operating-expenses | 18666 | 40053.2 | 45152.4 | 38842.7 | |||||||||||||||||
income-statement-row.row.cost-and-expenses | 77055.41 | 87997.2 | 96425.2 | 89706.7 | |||||||||||||||||
income-statement-row.row.interest-income | 63.26 | 63.3 | 47.1 | 76.7 | |||||||||||||||||
income-statement-row.row.interest-expense | 2240.91 | 2240.9 | 1307.8 | 712.2 | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 24762.64 | - | - | - | |||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -1462.29 | -1462.3 | 191.2 | 919.7 | |||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-operating-expenses | -20425.25 | -221 | 12200 | 12364.1 | |||||||||||||||||
income-statement-row.row.total-operating-expenses | -1462.29 | -1462.3 | 191.2 | 919.7 | |||||||||||||||||
income-statement-row.row.interest-expense | 2240.91 | 2240.9 | 1307.8 | 712.2 | |||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 12820.26 | 2046 | 2119.7 | 3980.6 | |||||||||||||||||
income-statement-row.row.ebitda-caps | 13416.67 | - | - | - | |||||||||||||||||
income-statement-row.row.operating-income | 596.4 | 596.4 | -2041.8 | -5299 | |||||||||||||||||
income-statement-row.row.income-before-tax | -865.89 | -865.9 | -1850.6 | -4379.3 | |||||||||||||||||
income-statement-row.row.income-tax-expense | 1208.02 | 1208 | 271.1 | -66.5 | |||||||||||||||||
income-statement-row.row.net-income | -2073.91 | -2073.9 | -2121.7 | -4312.8 |
Często zadawane pytania
Ile wynosi Dong Sung Bio Pharm.Co.,Ltd. (002210.KS) aktywów ogółem?
Dong Sung Bio Pharm.Co.,Ltd. (002210.KS) całkowite aktywa to 114973284037.000.
Jaki jest roczny przychód przedsiębiorstwa?
Roczny przychód to 43786401591.000.
Jaka jest marża zysku firmy?
Marża zysku firmy to 0.464.
Czym są wolne przepływy pieniężne firmy?
Wolne przepływy pieniężne to -228.151.
Jaka jest marża zysku netto przedsiębiorstwa?
Marża zysku netto to -0.023.
Jaki jest całkowity przychód firmy?
Całkowity przychód to 0.007.
Co to jest Dong Sung Bio Pharm.Co.,Ltd. (002210.KS) zysk netto (dochód netto)?
Zysk netto (dochód netto) wynosi -2073909512.000.
Jakie jest całkowite zadłużenie firmy?
Całkowite zadłużenie to 43272811605.000.
Ile wynoszą koszty operacyjne?
Wydatki operacyjne to 40053242263.000.
Jaka jest wartość gotówki firmy?
Środki pieniężne przedsiębiorstwa to 6435381432.000.